B
leichmar Fonti & Auld LLP (BFA) has filed a securities‑fraud class action against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and select senior executives. The suit alleges that the company misrepresented leasing activity and occupancy levels, leading to a sharp decline in share price. Investors who hold Alexandria stock can obtain details at https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit. A deadline of January 26, 2026 allows shareholders to request the court appoint a lead counsel. The complaint invokes Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and is pending in the U.S. District Court for the Central District of California under the caption *Hern v. Alexandria Real Estate Equities, Inc., et al.*, No. 2:25‑cv‑11319.
**Why Alexandria is sued**
Alexandria is a real‑estate investment trust whose tenants are largely life‑science firms. During the period in question, the company touted robust leasing volume and a promising pipeline for a Long Island City property, claiming “solid” leasing and a pipeline ready to meet future demand. In reality, occupancy rates were lower and leasing activity slowed, prompting a $323.9 million impairment charge—$206 million of which was attributed to the Long Island City asset.
**Stock plunge**
On October 27, 2025, Alexandria released 3Q 2025 results that fell short of expectations and cut its fiscal‑year guidance. The company cited lower occupancy and slower leasing, and announced a $323.9 million impairment, with $206 million tied to Long Island City. It also warned of potential 4Q impairments ranging from $0 to $685 million. The news sent the stock down $14.93 per share (≈19 %) from $77.87 to $62.94.
**What you can do**
If you own Alexandria shares, you may have a claim. BFA offers contingency‑fee representation at no cost to you; shareholders are not liable for litigation expenses. The firm will seek court approval for any fees and expenses. Submit your information at https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit or contact Ross Shikowitz ([email protected], 212‑789‑3619).
**Why choose BFA**
BFA is a premier international plaintiff firm, recognized by Chambers USA, The Legal 500, ISS SCAS, and others. Its attorneys have earned titles such as “Elite Trial Lawyers” (National Law Journal) and “SuperLawyers” (Thomson Reuters). Recent victories include a $900 million recovery from Tesla’s board and $420 million from Teva Pharmaceutical Industries. For more on BFA and its team, visit https://www.bfalaw.com.
